[1] |
SHI Yanfeng, CHENG Si, XU Zhe, LIU Yang, LI Hao, WANG Yongjun.
Association of CRP Gene rs3093068 Polymorphism with Ischemic Stroke Risk Factors and Stroke Outcome
[J]. Chinese Journal of Stroke, 2022, 17(03): 236-243.
|
[2] |
MA Xiaoqing, REN Yuqian, NI Qinshuai, LI Guangwen, GUO Yunliang.
Mechanism of C1q and Tumor Necrosis Factor Related Protein 6 Destroying the Blood-Brain Barrier after Cerebral Ischemia Reperfusion Injury in Rats
[J]. Chinese Journal of Stroke, 2022, 17(03): 292-300.
|
[3] |
CHEN Zhengyu, CHEN Guofang, CHEN Tong, MA Dongjiao.
Influencing Factors of Leukoaraiosis at Different Brain Regions in Patients with Intravenous Thrombolysis for Acute Ischemic Strok
[J]. Chinese Journal of Stroke, 2021, 16(12): 1248-1252.
|
[4] |
DENG Qi-Le, WU Jie-Hong, CHEN Ji-Xiang.
Progress of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in the Treatment of Ischemic Stroke
[J]. Chinese Journal of Stroke, 2021, 16(08): 850-854.
|
[5] |
ZHENG Ya-Li, YU Rui-Xiao, YU Yong-Peng,BAI Jia-He.
Brain Parenchymal Enhancement Predicts Hemorrhagic Transformation after Endovascular Treatment in Acute Cerebral Infarction with Anterior Circulation Large Vessel Occlusion
[J]. Chinese Journal of Stroke, 2021, 16(02): 181-186.
|
[6] |
HUANG Jing, LYU Xue-Feng, ZHANG Jin-Xin, ZHANG Chun-Ya.
Association of Interleukin-10 Promoter Gene Polymorphism with Ischemic Stroke: a Meta Analysis
[J]. Chinese Journal of Stroke, 2020, 15(09): 978-987.
|
[7] |
LIU Xiao-Wei, HU Wen-Li.
Impact of Leukoaraiosis on Symptomatic Intracranial Hemorrhage and Functional Outcome after Intravenous
Thrombolysis in Elderly Patients with Acute Cerebral Infarction
[J]. Chinese Journal of Stroke, 2020, 15(06): 650-654.
|
[8] |
ZHOU Hong-Yu, SUO Yue, CHEN Wei-Qi, WANG Yong-Jun.
Progress of Ring Finger Protein 213 Gene-related Cerebrovascular Disease
[J]. Chinese Journal of Stroke, 2020, 15(02): 195-201.
|
[9] |
ZHANG Qing, ZHANG Bei, LI Ya-Jun.
Progress of Role of Progranulin in Nervous System Diseases
[J]. Chinese Journal of Stroke, 2019, 14(07): 733-739.
|
[10] |
ZHANG Min, MA Li, ZHAO Yong-Mei, LYU Yan-Min, LONG Hui-Deng, PANG Li-Juan.
Progress in Pathophysiological Mechanism of Matrix Metalloproteinases 9 and its Gene Polymorphism in Ischemic Cerebral Injury
[J]. Chinese Journal of Stroke, 2019, 14(05): 504-510.
|
[11] |
XU Chang, XU Jun,ZHANG Zhi-Yu, SUN Yi, HUANG Dan-Qing, WANG Bian-Rong.
Relationship of Homocysteine with Renal Dysfunction in Patients with Leukoaraiosis
[J]. Chinese Journal of Stroke, 2019, 14(02): 106-110.
|
[12] |
LI Shi,LYU Man-Hua.
Progress of SphK1/S1P Signaling Pathway in the Mechanism of Cerebral Ischemia Reperfusion Injury
[J]. Chinese Journal of Stroke, 2018, 13(12): 1327-1331.
|
[13] |
Nadire·Aiziretiaili, FENG Hong-Liang, ZHANG Shuai-Mei, WANG Mei-Yao, LIU Yu-Min.
Analysis of Related Factors of Leukoaraiosis Based on Data Mining
[J]. Chinese Journal of Stroke, 2018, 13(10): 1019-1024.
|
[14] |
ZENG Tao, XIAO Xuan-Hao, XU Bang-Lao, LEI Xiu-Xia, LI Ze, ZHOU Jin, HUANG Hui, PAN Xiao-Ping.
Association of CYP2C19 Gene Polymorphisms with Risk of Recurrent Stroke in First-ever Ischemic Stroke Patients with Clopidogrel for Secondary Prevention
[J]. Chinese Journal of Stroke, 2018, 13(09): 908-914.
|
[15] |
Wang Yi-Long.
Strategy Selection of Antiplatelet Therapy for Ischemic Stroke in terms of the Ethnic Differences between Easterners and Westerners
[J]. Chinese Journal of Stroke, 2018, 13(05): 494-499.
|